PillRx only · Solution · Intravenous
Rocuronium Bromide
Rocuronium Bromide
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.394
Latest avg · Apr 22, 2026
+0%
Since Mar 18, 2026
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
99
Rx · 2026 Q1
235
Units dispensed
-81%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | unknown | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 15, 2023SHORTAGEDrug shortage: Rocuronium Bromide Injection (XGen Pharmaceuticals DJB, Inc.)
Rocuronium Bromide Injection — reported in shortage by XGen Pharmaceuticals DJB, Inc.. Therapeutic category: Anesthesia.